Target intelligence / Profile preview

DNA promoter region

Molecular classification
Nucleic acid, Regulatory element, Other
01

Overview

DNA promoter regions are essential regulatory segments of DNA located typically upstream of the transcription start site of a gene (National Human Genome Research Institute, 2023). Their primary biological function is to serve as a scaffold for the assembly of the transcription pre-initiation complex, including RNA polymerase and various transcription factors (Nature Education, 2014). By controlling the frequency and timing of transcription, promoters act as the fundamental gatekeepers of gene expression. In many diseases, particularly oncology, the dysregulation of promoter activity through genetic mutations or epigenetic modifications like hypermethylation leads to the silencing of tumor suppressor genes (Herman & Baylin, 2003). Conversely, promoter hypomethylation or mutations in specific elements, such as the TERT promoter, can drive the overexpression of oncogenes. Therapeutic strategies targeting these regions include small molecules like Mithramycin A, which binds to GC-rich sequences to displace transcription factors, and epigenetic drugs like Decitabine that inhibit DNA methyltransferases to reactivate silenced promoters (Gupta et al., 2017). Furthermore, advanced technologies such as CRISPR-mediated transcriptional modulation (CRISPRa/i) are being developed to target specific promoters for the treatment of genetic disorders (Puckett et al., 2017).

Other names
Promoter sequenceGene promoterTranscriptional regulatory elementPromoter DNA
02

Mechanism of action

Drugs targeting DNA promoter regions typically function by binding to specific DNA sequences (such as GC-rich regions) to physically displace transcription factors, intercalating into the DNA helix to prevent RNA polymerase progression, or inhibiting enzymes like DNA methyltransferases to alter the epigenetic methylation state of the promoter (Gupta et al., 2017; Herman & Baylin, 2003).

03

Biological functions

Transcription initiationGene expression regulationRNA polymerase bindingTranscription factor recruitment
04

Disease associations

CancerGenetic disorderInfectionInflammation
05

Safety considerations

GenotoxicityMutagenicityOff-target transcriptional dysregulationCytotoxicityRisk of secondary malignancies
06

Interacting drugs

Dactinomycin

6 more in the full profile.

07

Biomarkers

MGMT promoter methylation statusGSTP1 promoter hypermethylationSEPT9 promoter methylationTERT promoter mutationBRCA1 promoter methylation

Beyond the preview

Go deeper on DNA promoter region.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA promoter region.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call